It would have been helpful to the audience in this presentation to have made a more explicit distinction between the human data and the preclinical data in mice. All of the comments about "extraordinary" or "curative" were in relation to data collected in mouse experiments, not trials in humans. Hopefully, the drug is as effective in humans, although the data released thus far appears to not support this. This is not to say the drug won't be a much needed improvement over the current standard of care, but frankly, not making this explicit distinction in the data presentation was a little misleading.
MAIA Biotechnology deserves SO much more attention than it's gotten. I'm super glad Regeneron has noticed and begun collaboration in clinical trials.
About time... the preclinicals were done in 2015.
MAIA has arrived and is here to stay! I think we will be hearing a lot more from them in the future...
They’ve basically cured cancer??
It would have been helpful to the audience in this presentation to have made a more explicit distinction between the human data and the preclinical data in mice. All of the comments about "extraordinary" or "curative" were in relation to data collected in mouse experiments, not trials in humans. Hopefully, the drug is as effective in humans, although the data released thus far appears to not support this. This is not to say the drug won't be a much needed improvement over the current standard of care, but frankly, not making this explicit distinction in the data presentation was a little misleading.
Human trials are underway. So results are TBD. Starts with mice then into human trials. So far, all good readouts in patients
So far the data on human far exceeds standard of care, chemo